Project Grant R01DK142422
- Federal Grant Award Summary The University of Miami received a $2.78 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on September 23, 2025, with completion anticipated by August 31, 2029. This translational research award supports investigation into the role of vascular fibroblasts in postoperative venous stenosis following arteriovenous...
- Federal Project Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine received a $182,296 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 26, 2025, with completion anticipated by December 31, 2027. This award supports basic biomedical research investigating the role of neuronal KV7.2 ion...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $437,010 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 11, 2025, with completion targeted for August 31, 2027. This award supports research and development of the Smart Arteriovenous (SAVE) stent—an innovative biodegradable magnesium stent...
- Federal Project Grant Summary Anova Biomedical, Inc. received a $298,371 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period July 1, 2025 through June 30, 2026. The award funds development and advancement of the DeNovo1 Graft, a biodegradable arteriovenous graft (AVG) designed to address critical shortcomings in current vascular access...
- Federal Grant Award Summary Microvascular Tissues, Inc. received a $700,000 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on September 17, 2025, with completion targeted for August 31, 2026. The award funds evaluation of Microvascular Tissue Graft (MVASC), a novel human structural allograft product developed to treat diabetic peripheral...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $832,783 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 1, 2026, through November 30, 2029. The research initiative will define cellular and molecular signatures of inflammation associated with chronic kidney disease (CKD)...
- Federal Project Grant Award Summary The University of Michigan received a $196,418 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through May 31, 2030. This research grant supports a comprehensive investigation into novel diagnostic and therapeutic approaches for acute kidney injury (AKI) in patients with cirrhosis. The...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Virginia $162,476 on June 3, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on renin cell identity and function. The project, titled "The Reninness Score: Integrative Analysis of Multi-Omic Data to Define Renin Cell Identity," will be completed by December 31, 2026. The research...
- Federal Project Grant Award Summary The University of Michigan received a $690,854 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on February 1, 2026, with a completion date of December 31, 2030. The research project, titled "Mechanisms of Epithelial Cell State Changes During Kidney Injury," investigates molecular and genetic...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $242,250 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 12, 2025, with completion scheduled for July 31, 2027. The award funds a research initiative titled "Understanding Diabetes and Peripheral Artery Disease-Related Amputation...
Federal Project Grant Award Summary The University of Miami's Office of Research Administration – School of Medicine received a $715,188 project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 15, 2026, with a completion date of December 31, 2029. This research initiative focuses on investigating the critical role of endothelial inflammation in arteriovenous (AV) fistula failure, a significant clinical problem affecting end-stage renal disease patients requiring hemodialysis vascular access. The project delivers fundamental and translational research products designed to elucidate the cellular and molecular mechanisms underlying postoperative venous stenosis in AV fistulas. Specifically, the research employs integrated molecular and cellular approaches utilizing both in vivo and in vitro models to demonstrate the causality of endothelial type VIII collagen accumulation in fistula remodeling and to identify the transcriptional mechanisms controlling COL8A1 gene activation in endothelial cells following AV anastomosis. The research is expected to generate the first spatial transcriptomic cellular atlas of human stenotic and non-stenotic venous segments obtained during surgical transposition, advancing scientific understanding of vascular access failure mechanisms that contribute to improved prevention and treatment strategies for the hemodialysis population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $715.2k | 2/15/26 |